“SETsquared has made a tangible benefit to our business. The Entrepreneur in Residence and Business Review Panel sessions enabled us to critically evaluate our business strategy with experienced entrepreneurs.
Their newsletters and social media platforms have also given us a voice that extends beyond the southwest.”
Providing clinicians with rapid tests to make their first antibiotic prescription, the right prescription.
Top 3 achievements:
Collaborative work with University of Bristol was published by ACS Biomaterials; a key milestone that verified and established the foundations of the NANOPLEX® technology
In 2021, FluoretiQ was selected to join the prestigious Longitude Prize cohort to address rising levels of antimicrobial resistance (AMR)
In 2022, FluoretiQ closed a £1.1 million pre-series A investment led by Deepbridge Capital LLP which accelerated their flagship product development programme and grew key elements of the business. Taking their total funding to £2.3m